Palavras-chave
Oftalmoscopia
Retinopatia diabética
Como Citar
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Resumo
Objetivo: Analisar o valor prognóstico da retinopatia diabética identificada por fundoscopia na predição de eventos cardiovasculares maiores em pacientes com diabetes mellitus tipo 2. Métodos: Trata-se de uma revisão integrativa da literatura realizada através das bases PubMED, Biblioteca Virtual em Saúde (BVS) e Periódico CAPES, usando os descritores: “Diabetic Retinopathy”, “Diabetes Mellitus, Type 2” e “Cardiovascular Diseases”, e obtendo o truncamento de pesquisa: (Diabetic Retinopathy) AND (Diabetes Mellitus, Type 2) AND (Cardiovascular Diseases). Foram encontrados 10.085 artigos, filtrados conforme critérios de inclusão (idiomas português, inglês e espanhol; período de 2021 a 2026; artigos completos) e exclusão (artigos duplicados, resumos, fora do escopo). Resultados: A retinopatia diabética está fortemente associada ao aumento do risco cardiovascular sistêmico, funcionando como marcador precoce de dano vascular. A progressão da doença reflete um processo integrado de inflamação, disfunção endotelial e alterações metabólicas que acometem simultaneamente micro e macrovasculatura. Além disso, a fundoscopia, associada a biomarcadores e novos modelos preditivos, destaca-se como ferramenta promissora para estratificação de risco e intervenção precoce. Conclusão: A retinopatia diabética configura-se como um importante marcador precoce de risco cardiovascular sistêmico. Sua identificação deve orientar uma abordagem clínica integrada e intensiva para redução de desfechos adversos.
Referências
AGAPITOU C, et al. Investigation of the potential association between atherosclerotic cardiovascular disease risk score and diabetic retinopathy in patients with type 2 diabetes: A cross-sectional study. Biomedicines, 2025; 13(3): 633.
ALATRANY AS, et al. The retina as a window into detecting subclinical cardiovascular disease in type 2 diabetes. Scientific Reports, 2025; 15(1): 27968.
CHEN J, et al. Does 10-year atherosclerotic cardiovascular disease risk predict incident diabetic nephropathy and retinopathy in patients with type 2 diabetes mellitus? Results from two prospective cohort studies in southern China. Diabetes & Metabolism Journal, 2025; 49(2): 298–310.
CHEN Y, et al. Association between severity of diabetic retinopathy and cardiac function in patients with type 2 diabetes. Journal of Diabetes Research, 2023; 2023(1): 6588932.
GAO L, et al. Proliferative diabetic retinopathy in patients with type 2 diabetes correlates with the presence of atherosclerosis cardiovascular disease. Diabetology & Metabolic Syndrome, 2021; 13(1): 48.
IVANESCU A, et al. Predictors of diabetic retinopathy in type 2 diabetes: A cross-sectional study. Biomedicines, 2024; 12(8): 1889.
KIM Y, et al. Discovering potential pathways between type 2 diabetes mellitus and diabetic retinopathy: A big data analysis of the South Korean National Sample Cohort. Medicine, 2023; 102(31): e34576.
LI J, et al. Association of the systemic immuno-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with diabetic microvascular complications. Frontiers in Endocrinology, 2024; 15(1): e1367376.
LI L, et al. Relationship between atherosclerotic cardiovascular disease and diabetic retinopathy in patients with type 2 diabetes mellitus. Medicine, 2024; 103(19): e38051.
LIANG Y, et al. Predicting vision-threatening diabetic retinopathy in patients with type 2 diabetes mellitus: Systematic review, meta-analysis, and prospective validation study. Journal of Global Health, 2024; 14(1): 04192.
MAHAJAN M, et al. Evaluation of nail fold capillaroscopy changes in patients with diabetic retinopathy and healthy controls, and its correlation with disease duration, HbA1c levels and severity of diabetic retinopathy: An observational study. Indian Journal of Dermatology, Venereology and Leprology, 2024; 90(6): 782–788.
MANSOUR A, et al. Microvascular and macrovascular complications of type 2 diabetes mellitus: Exome wide association analyses. Frontiers in Endocrinology, 2023; 14(1): 1143067.
MWANGU JK, et al. Correlates of retinopathy in persons living with type 2 diabetes at a clinic in Zambia. The Pan African Medical Journal, 2024; 49(1): 83.
RAJA SA, et al. Prevalence and associated factors of diabetic retinopathy among type 2 diabetes mellitus patients in Brunei Darussalam: A cross-sectional study. Korean Journal of Ophthalmology, 2022; 36(1): 26–35.
RIJAL P, et al. Subclinical right ventricular dysfunction in patients with asymptomatic type 2 diabetes mellitus: A cross-sectional study. Indian Heart Journal, 2023; 75(6): 451–456.
ROŞU CS, et al. Cardiovascular risk factors as independent predictors of diabetic retinopathy in type II diabetes mellitus: The development of a predictive model. Medicina (Kaunas, Lithuania), 2024; 60(10): 1617.
SARDARINIA M, et al. Incidence and risk factors of severe non-proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study. Journal of Diabetes Investigation, 2022; 13(2): 317–327.
SHEN R, et al. Associations of cardiovascular health assessed by life’s essential 8 with diabetic retinopathy and mortality in type 2 diabetes. Primary Care Diabetes, 2023; 17(5): 420–428.
SIGIT FS, et al. Hypertriglyceridemic waist phenotype in relation to diabetes mellitus and cardiovascular diseases in the Indonesian and Korean populations: evidence from two national surveys. Diabetology & Metabolic Syndrome, 2025; 17(1): 401.
TAN H, et al. Prevalence and risk factors of diabetic retinopathy among Chinese adults with type 2 diabetes in a suburb of Shanghai, China. PloS One, 2022; 17(10): e0275617.
WANG GX, et al. Development and validation of a diabetic retinopathy risk prediction model for middle-aged patients with type 2 diabetes mellitus. Frontiers in Endocrinology, 2023; 14(1): 1132036.
WANG H, et al. Association of monocyte-lymphocyte ratio and proliferative diabetic retinopathy in the U.S. population with type 2 diabetes. Journal of Translational Medicine, 2022; 20(1): 219.
YANG Z, et al. Risk of diabetic retinopathy and retinal neurodegeneration in individuals with type 2 diabetes: Beichen Eye Study. Frontiers in Endocrinology, 2023; 14(1): 1098638.
YOUSRI NA, et al. Metabolic and metabo-clinical signatures of type 2 diabetes, obesity, retinopathy, and dyslipidemia. Diabetes, 2022; 71(2): 184–205.
YU C, et al. Birth weight, cardiovascular health, and microvascular complications in individuals with diabetes mellitus. Diabetes & Metabolism Journal, 2025; 49(5): 1075–1086.
ZUO W, YANG X. Construction of a nomogram for predicting the risk of all-cause mortality in patients with diabetic retinopathy. Frontiers in Endocrinology, 2025; 16(1): 1493984.